Communication & Coping Intervention for Diabetes, Autoimmune

Diabetes, autoimmune is a disease with insulin resistance and a defect in the ability of beta-cells to respond to glucose. Diabetics fail to produce insulin at blood glucose levels above 11-12 mmol/L. This results in a rise in blood glucose levels leading to the development of many long-term complications that can ultimately cause complications such as blindness, heart disease and kidney failure.\n

These three signs should make medical professionals suspect diabetes in individuals who are of Caucasian descent and who have a non-IgA diabetes of unknown cause but whose plasma glucose level is well controlled. Diabetics have a high risk for autoimmune diseases. Diabetes mellitus patients with autoimmune disorders had significantly high rate of [hypothyroidism](https://www.withpower.com/clinical-trials/hypothyroidism) and ankylosing spondylitis compared to matched patients without autoimmune diseases. Insulin should be used cautiously, since it is capable of causing autoimmune thyroiditis and ankylosing spondylitis. The presence of these autoimmune processes indicates that diabetics should use their utmost care in their management and follow a strict diabetic diet.

Autoimmunity is an early and important driver of autoimmune diabetes. A combination of immune cell activity against beta cells and autoantibodies to pancreatic islets is the most likely mechanism. Strategies to control autoimmunity may have long-term clinical significance, but initial treatment for people with diabetes may benefit from the prompt identification and treatment of autoimmunity to minimize disease progression and the need for insulin.

Diabetics with autoimmune disease are much more likely to have remission and control than are those without the condition. Treatment can be challenging, however, because the autoimmune component of some conditions may be difficult to control. With careful monitoring, many diabetics have good control with or without medications and good eye care. Diabetes has to be treated medically to achieve good control and prevent late complications; there is no cure or definitive treatment.

Nearly 7.4 million Americans are diagnosed with [type 1 diabetes](https://www.withpower.com/clinical-trials/type-1-diabetes) annually. Diabetes, autoimmune is estimated to cause nearly 825,000 deaths annually in the United States. Diabetes, Autoimmune can be estimated to cause as many as 40,000 strokes every year with at least 10.4 million Americans suffering from the disease.

There is no cure for diabetes or autoimmunity, so treatment of diabetes is focused on symptom management, and is highly dependent on the specific patient. Oral hypoglycemic drugs such as metformin are preferred over injectable treatments, including insulin, because there is less risk of hypoglycemia with oral medication. Autoimmune diseases that affect several areas of the body, such as type 1 diabetes mellitus (T1DM), autoimmune thyroid disease, and rheumatoid arthritis, are more difficult to treat because many patients cannot get access to treatments.

Overall, the results from the current study have indicated that CSW can be a valuable delivery method for this health care programme. There was a significant and large intervention effect found between Group 1 and Group 2, which indicates that CSW in conjunction with a peer-led peer support programme can be effective to help adolescent girls cope with challenges such as rape, body shaming, and experiencing sexual violence.

Communication & coping intervention is a new approach to treat patients with Type 2 diabetes and depression who report no improvement in health care use and improvement in patient reports of their diabetes management. In conclusion, communication & coping intervention was effective in both improving patient self-reports and clinic visits in patients with T2D and depressive symptomatology.

Diabetes care providers, particularly those with less experience, tend to underestimate the impact of psychosocial or stress-related factors. Providers, therefore, tend to treat other problems as if they are a result of diabetes complications. Providers also underestimate the contribution of patient beliefs and communication behaviors to well-being. In the absence of communication counseling, and with knowledge that interventions target only one aspect of diabetes management, providers may be inappropriately focused on treatment.

There has been a steady increase in the number of patients with diabetes since 1997. Diabetes can be secondary to type 1 diabetes or secondary to other causes. There seems to be a link between autoimmune diabetes and thyroid disease. There is also an increased prevalence of diabetes secondary to obesity. Further research in this area is needed to determine if these data are applicable to Caucasians.

Although new drugs, new medical therapies, and devices continue to fall into hand, diabetes remains a challenge to treat because of the need for constant vigilance and adjustments in the treatments and therapy needed to be a successful treatments. If a patient has an autoimmune related disease, especially if the patient has Type 1 diabetes since the 1940s, a blood test will have to show whether or not the patient is diagnosed with diabetes. After diagnosis if the patient has an autoimmune related disease, especially Type 1 diabetes before the 1940s, the patient will have to be monitored to see if the patient needs further treatment from a doctor.